Company: PFSA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004396
Chunk: 1009

Company: Profusa, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 6
Chunk 1009
---
 I-Bankers and Dawson James have agreed that neither they nor their designees will be
permitted to exercise the warrants after the five year anniversary of the effective date of the registration statement of
which the IPO forms a part. The warrants and such shares purchased pursuant to the warrants have been deemed compensation by FINRA
and are therefore subject to a lock-up for a period of 180 days immediately following the date of the effectiveness of the
registration statement of which the IPO forms a part pursuant to FINRA Rule 5110I(1). Pursuant to FINRA Rule 5110I(1),
these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the
economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the
registration statement of which the IPO forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated for a
period of 180 days immediately following the effective date of the registration statement of which the IPO forms a part except
to any underwriter and selected dealer participating in the offering and their bona fide officers or partners. The warrants grant to
holders demand and “piggy back” rights for periods of five and seven years, respectively, from the effective date of the
registration statement of which the IPO forms a part with respect to the registration under the Securities Act of the shares
issuable upon exercise of the warrants. The Company will bear all fees and expenses attendant to registering the securities, other
than underwriting commissions, which will be paid for by the holders themselves. The exercise price and number of shares issuable
upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or the
Company’s recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances
of shares at a price below its exercise price. The Company will have no obligation to net cash settle the exercise of the warrants.
The holder of the warrants will not be entitled to exercise the warrants for cash unless a registration statement covering the
securities underlying the warrants is effective or an exemption from registration is available.

Merger
Agreement

On
November 7, 2022, NorthView entered into a Merger Agreement and Plan of Reorganization (the “Merger Agreement”), by and among
Merger Sub., and Prof